-
Innovator Embraces Psychedelic Horizons With New Schedule 1 Manufacturing License
Thursday, July 27, 2023 - 4:23pm | 462A new player is entering the psychedelics production space. Small molecule therapeutic contract developer Societal CDMO Inc. (NASDAQ: SCTL) has secured a DEA Schedule 1 Controlled Substances manufacturer’s license and is entering the biopharma industry’s psychedelic drugs subsection....